Brief: Kuros Biosciences Appoints Michael Grau As CFO Effective Feb 1, 2018
Dec 14 (Reuters) - KUROS BIOSCIENCES AG KURN.S :
* ANNOUNCED APPOINTMENT OF MICHAEL GRAU AS CHIEF FINANCIAL
OFFICER
(CFO) EFFECTIVE FEB 1, 2018
* MICHAEL GRAU SUCCEEDS HARRY WELTEN, WHO WILL STEP DOWN AS
CFO ON
FEBRUARY 1, 2018
Source text for Eikon: ID:nTENoqeama
Further company coverage: KURN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million